ShakeelModakMD

Clinical Trials

• Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation Start of enrollment: 2004 May 01

  Terminated

  Phase 1

• Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma Start of enrollment: 2006 May 01

  Recruiting

  Phase 2

• Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2006 Aug 01

  Completed

  Phase 1

• Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma Start of enrollment: 2005 Sep 09

  Completed

  Phase 1

• Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 Start of enrollment: 2001 Oct 01

  Terminated

  Not Applicable

• Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma Start of enrollment: 2009 Apr 02

  Completed

  Phase 1

• Intraperitoneal RIT With 131I-8H9 for Pts With DSRCT and Other Solid Tumors Involving the Peritoneum Start of enrollment: 2010 Apr 01

  Terminated

  Phase 1

• Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma Start of enrollment: 2010 Apr 29

  Completed

  Phase 2

• Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) Start of enrollment: 2013 Aug 28

  Completed

  Phase 1

• Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma Start of enrollment: 2016 Jan 01

  Active, not recruiting

  Phase 1

• Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers Start of enrollment: 2019 Feb 22

  Terminated

  Phase 1, Phase 2

• A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum Start of enrollment: 2019 Jul 15

  Recruiting

  Phase 2

• Join now to see all